Expansion Capital - North Africa
Expansion capital / capital transmission transactions involving medium-sized companies in the Maghreb countries (Morocco, Algeria and Tunisia) and in the Mashreq countries (Egypt, Lebanon and Jordan);
Working as an active shareholder, either individually or alongside other investors, with company managers to assist with their growth and development plans;
Individual equity holdings of between €5 million and €15 million.
Ophalia Pharma – A Tunisian company specialised in the production and export of generic medicaments (www.opaliapharma.com)
Emteyco – A Moroccan company specialised in the manufacture of metal masts for electricity and telecommunication networks.
Oksa – A Moroccan electronics company specialised in optimising the performance of medium- and low-voltage electricity networks (www.oksamaroc.com)
Contact Paris
-
Fabrice Callet - Managing Partner (Emerging Markets Group)
11 years experience in private equity.
Tel: +33 1 56 37 88 11
Email: fabrice.callet@sgam.com-
Andrew Brown - Chief Investment Officer, Partner (North Africa)
12 years experience in private equity in emerging countries (Africa).
Tel: +33 1 56 373308
Email: andrew.brown@sgam.com
-
Contact Cairo
-
Rafik Dalala - Director
10 years experience in expansion capital and investment banking.
Tel: +202 27 92 7057
Email: rafik.dalala@sgam.comContact Casablanca
-
Anas Guennoun - Director
10 years experience in expansion capital and investment banking.
Tel: +212 5 22 79 08 02
Email: anas.guennoun@sgam.com
-
Contact Tunis
-
Adel Goucha - Director
10 years experience in expansion capital and investment banking.
Tel: + 216 71 901 222
Email: adel.goucha@sgam.com